AR and lung carcinoma: Thus, 9c is a promising therapeutic agent for lung cancer, and further research efforts should focus on elucidating the mechanisms involved in detail.The binding modes of triazine derivatives were identified through a molecular docking study at hA1 and hA3 AR.